(PharmaNewsWire.Com, April 07, 2017 ) Market Data Forecast recently published a report on the North America Diabetic Retinopathy Market which estimates the market to grow from USD 2.14 billion from 2016 to USD 2.86 billion by 2021 with a high CAGR of 6.05%.
North America leads the global diabetic retinopathy market due to huge number of aging population. Diabetic retinopathy is a result of long term diabetes that affects eyes. It's triggered by failure of the blood vessels of the light-sensitive tissue at the back of the eye (retina). At first, diabetic retinopathy may show only slight vision difficulties or can say no symptoms. Eventually, it can cause blindness.
Increasing management financial support, alteration in lifestyle, rising occurrence of diabetics, and global elderly population are the factors driving the market growth. However, dearth of accurate diagnosis and prolonged approval time for drugs are hampering the growth of global diabetic retinopathy market. Increasing healthcare awareness is also powering the raise of global diabetic retinopathy market.
The products are segmented based on Type of Treatment, Indication and End Users and studied for a deep-level understanding of the Diabetic Retinopathy Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on Type of Treatment: Anti-Vascular Endothelial Growth Factor (VEGF) drug Intraocular Steroid Injection Laser Surgery Vitrectomy
Based on Indication: Non-Proliferative Diabetic Retinopathy (NPDR) o Mild o Moderate o Severe Proliferative Diabetic Retinopathy (PDR)
Based on End Users: Hospitals Ophthalmic Clinics Ambulatory Surgical Centers
On the basis of geography, the North America market is analyzed under regions namely United States and Canada. North America is predicted to contribute maximum revenue share in access by end of forecast timeframe. The major companies dominating the North America Diabetic Retinopathy Market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Alimera Science Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., and Ampio Pharmaceuticals Inc.
Further, technological breakthroughs in retinal screening methods and equipment like utilization of slit lamps and launching of new products like Gly-230 & Optima are the factors predicted to drive the industry expansion. Growing occurrence of diabetes predicted to affect more than 4.6% of world population will also enhance the industry growth.
Scope of the North America Diabetic Retinopathy Market:
Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region
To detect major focus areas of industrial growth Segment-level analysis on basis of Type of Treatment, Indication along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
